Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


eCardio Predicts 24/7 Patient Compliance With eVolution Cardiac Monitor

This article was originally published in The Gray Sheet

Executive Summary

eCardio Diagnostics believes the small, one-piece ambulatory design of its newest cardiac monitor will encourage consistent patient compliance, allowing physicians to track patients around the clock

You may also be interested in...

Report Calls For Proactive Reimbursement Policy On Remote Monitoring

By investing $1,000 per patient, or $10.1 billion per year, to promote telemonitoring of chronically ill patients, health care payers could lower annual health care costs in the U.S. by $22.2 billion, according to estimates by Kauffman Foundation economist Robert E. Litan

Pipeline Watch: Vericiguat, Evinacumab Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts